An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS | Zendy

David A. Morrow | Zendy; Elliott M. Antman | Zendy; Steven Snapinn | Zendy; Carolyn H. McCabe | Zendy; Pierre Théroux | Zendy; Eugene Braunwald | Zendy

Open Access

An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS

Author(s) -

David A. Morrow,

Elliott M. Antman,

Steven Snapinn,

Carolyn H. McCabe,

Pierre Théroux,

Eugene Braunwald

Publication year - 2002

Publication title -

european heart journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.336

H-Index - 293

eISSN - 1522-9645

pISSN - 0195-668X

DOI - 10.1053/euhj.2001.2738

Subject(s) - medicine , timi , tirofiban , cardiology , acute coronary syndrome , st elevation , framingham risk score , percutaneous coronary intervention , myocardial infarction , disease

We evaluated the TIMI Risk Score for Unstable Angina and Non-ST Elevation Myocardial Infarction for predicting clinical outcomes and the efficacy of tirofiban in non-ST elevation acute coronary syndromes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research